Intelligence Platform
Patents
Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12428416
ERK inhibitors and uses thereof
granted patentUS 12428415
Matriptase 2 inhibitors and uses thereof
granted patentUS 12428395
Heterocyclic compounds as kinase inhibitor and uses thereof
granted patentUS 12428379
Acylsulfonamide KAT6A inhibitors
granted patentUS 12421273
Ectonucleotidase inhibitors and methods of use thereof
granted patentUS 12421249
Inhibitors of APOL1 and methods of using same
granted patentUS 12419890
Administration of sumo-activating enzyme inhibitor and checkpoint inhibitors
granted patentUS 12421269
SGLT2/DPP4 inhibitor and application thereof
granted patentUS 12419873
Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related diseases
granted patentUS 12421253
Tetrahydropyridopyrimidine pan-KRas inhibitors
granted patentUS 12421236
Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor
granted patentUS 12421231
Azaindole derivatives and their use as ERK kinase inhibitors
granted patentUS 12421228
Naphthyridine derivatives as PRC2 inhibitors
granted patentUS 12414953
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
granted patentUS 12414981
JNK inhibitors for use in treating and preventing neurodegenerative disorders
granted patentUS 12415866
Monoclonal antibody inhibitor of Factor XIIa
granted patentUS 12409225
Ras inhibitors
granted patentUS 12410184
Crystalline forms of a menin inhibitor
granted patentUS 12403141
Deuterated MK2 pathway inhibitors and methods of using the same
granted patentUS 12404243
Inhibitors of the Wnt/beta-catenin pathway
granted patentUS 12403196
Ras inhibitors
granted patentUS 12403154
Administration of sting agonist and checkpoint inhibitors
granted patentUS 12398154
Azaquinazoline pan-KRas inhibitors
granted patentUS 12398131
Thiadiazolyl derivatives as DNA polymerase theta inhibitors and uses thereof
granted